Intervention Review

You have free access to this content

Corticosteroids for tuberculous pleurisy

  1. Mark E Engel1,*,
  2. Patrice T Matchaba2,
  3. Jimmy Volmink3

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 23 JUL 2007

DOI: 10.1002/14651858.CD001876.pub2

Database Title

Additional Information

How to Cite

Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD001876. DOI: 10.1002/14651858.CD001876.pub2.

Author Information

  1. 1

    Faculty of Health Sciences, University of Cape Town, Department of Medicine, Observatory, South Africa

  2. 2

    Novartis Pharmaceuticals Corporation, East Hanover, USA

  3. 3

    University of Stellenbosch, Faculty of Health Sciences, Tygerberg, South Africa

*Mark E Engel, Department of Medicine, Faculty of Health Sciences, University of Cape Town, J47 Old Main Building, Groote Schuur Hospital, Observatory, 7925, South Africa. mark.engel@mrc.ac.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (220K)Full (276K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 1 Death from any cause.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 2 Residual fluid at 4 weeks.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 3 Residual fluid at 8 weeks.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 4 Presence of pleural thickening.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 5 Presence of pleural adhesions.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 6 Days to improvement in symptoms.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 7 Clinical symptoms after 7 days.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 8 Adverse events leading to treatment discontinuation.
[Analysis 1.9]
Analysis 1.9. Comparison 1 Corticosteroids versus control (placebo or no steroids), Outcome 9 HIV-associated events.
View Full Article (HTML) Summary (57K)Standard (220K)Full (276K)